These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34103058)

  • 1. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
    Lee C; Round JM; Klarenbach S; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Harm Reduct J; 2021 Jun; 18(1):61. PubMed ID: 34103058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada.
    Dubois C; Fernandes H; Lin M; Martins KJB; Dyck JRB; Klarenbach SW; Richer L; Jess E; Hanlon JG; Hyshka E; Eurich DT
    BMC Public Health; 2024 Mar; 24(1):859. PubMed ID: 38504198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis.
    Round JM; Lee C; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    BMC Public Health; 2020 Jun; 20(1):987. PubMed ID: 32576158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada.
    Lee C; Lin M; Martins KJB; Dyck JRB; Klarenbach S; Richer L; Jess E; Hanlon JG; Hyshka E; Eurich DT
    BMC Public Health; 2021 May; 21(1):843. PubMed ID: 33933061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
    Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Cannabis Authorization in Patients With Cancer in the Prelegalization Era: A Population-Based Study.
    Karim S; Cheung WY; Bu J; Jess E; Kerba M
    J Pain Symptom Manage; 2020 Jun; 59(6):1223-1231. PubMed ID: 31887404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada.
    Lee C; Voaklander D; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Inj Epidemiol; 2021 Apr; 8(1):33. PubMed ID: 33906699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study.
    Zongo A; Lee C; Dyck JRB; El-Mourad J; Hyshka E; Hanlon JG; Eurich DT
    Subst Use Misuse; 2022; 57(10):1633-1641. PubMed ID: 35866679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
    Rotermann M; Pagé MM
    Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario.
    AminiLari M; Busse JW; Turna J; MacKillop J
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1133-1139. PubMed ID: 35333612
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Vander Heiden J; Kish SJ
    Drug Alcohol Rev; 2023 Jul; 42(5):1104-1113. PubMed ID: 36908258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canada's cannabis legalization and drivers' traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Vander Heiden J; Asbridge M; Stockwell T; Macdonald S; Peterman BH; Kish SJ
    Drug Alcohol Depend; 2021 Nov; 228():109008. PubMed ID: 34508959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.
    Eurich D; Lee C; Zongo A; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck J
    J Epidemiol Community Health; 2020 Mar; 74(3):299-304. PubMed ID: 31831619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
    Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D
    Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interrupted time series evaluation of the effect of cannabis legalization on intentional self-harm in two Canadian provinces: Ontario and Alberta.
    Cusimano MD; Carpino M; Walker M; Saarela O; Mann R
    Health Promot Chronic Dis Prev Can; 2023 Sep; 43(9):403-408. PubMed ID: 37707352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients.
    Meng H; Page MG; Ajrawat P; Deshpande A; Samman B; Dominicis M; Ladha KS; Fiorellino J; Huang A; Kotteeswaran Y; McClaren-Blades A; Kotra LP; Clarke H
    Can J Anaesth; 2021 May; 68(5):633-644. PubMed ID: 33469735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study.
    Zongo A; Lee C; Dyck JRB; El-Mourad J; Hyshka E; Hanlon JG; Eurich DT
    BMC Cardiovasc Disord; 2021 Sep; 21(1):426. PubMed ID: 34507536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.
    Watson TM; Hyshka E; Bonato S; Rueda S
    Subst Use Misuse; 2019; 54(10):1691-1704. PubMed ID: 31076006
    [No Abstract]   [Full Text] [Related]  

  • 20. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.